Cornerstone Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.3M | Sell |
49,377
-408
| -0.8% | -$221K | 2.42% | 13 |
|
|
2025
Q4 | $28.8M | Sell |
49,785
-75
| -0.2% | -$42.4K | 2.84% | 10 |
|
|
2025
Q3 | $24.2M | Sell |
49,860
-345
| -0.7% | -$161K | 2.37% | 14 |
|
|
2025
Q2 | $20.4M | Buy |
50,205
+2,840
| +6% | +$1.19M | 2.13% | 19 |
|
|
2025
Q1 | $23.6M | Buy |
47,365
+392
| +0.8% | +$212K | 2.54% | 11 |
|
|
2024
Q4 | $24.4M | Sell |
46,973
-5,112
| -10% | -$2.81M | 2.57% | 12 |
|
|
2024
Q3 | $32.2M | Buy |
52,085
+615
| +1% | +$364K | 3.01% | 9 |
|
|
2024
Q2 | $28.5M | Buy |
51,470
+808
| +2% | +$463K | 2.87% | 9 |
|
|
2024
Q1 | $29.4M | Sell |
50,662
-99
| -0.2% | -$55.6K | 3.02% | 8 |
|
|
2023
Q4 | $26.9M | Sell |
50,761
-1,366
| -3% | -$661K | 2.95% | 9 |
|
|
2023
Q3 | $26.4M | Sell |
52,127
-175
| -0.3% | -$93.3K | 3.18% | 9 |
|
|
2023
Q2 | $27.3M | Buy |
52,302
+1,441
| +3% | +$778K | 3.16% | 8 |
|
|
2023
Q1 | $29.3M | Buy |
50,861
+306
| +0.6% | +$172K | 3.54% | 7 |
|
|
2022
Q4 | $27.8M | Buy |
50,555
+533
| +1% | +$282K | 3.57% | 9 |
|
|
2022
Q3 | $25.4M | Sell |
50,022
-468
| -0.9% | -$262K | 3.56% | 9 |
|
|
2022
Q2 | $27.4M | Sell |
50,490
-4,468
| -8% | -$2.46M | 3.51% | 8 |
|
|
2022
Q1 | $32.5M | Sell |
54,958
-2,143
| -4% | -$1.23M | 3.64% | 6 |
|
|
2021
Q4 | $38.1M | Sell |
57,101
-2,209
| -4% | -$1.38M | 4.06% | 3 |
|
|
2021
Q3 | $33.9M | Sell |
59,310
-1,687
| -3% | -$926K | 3.91% | 4 |
|
|
2021
Q2 | $30.8M | Sell |
60,997
-909
| -1% | -$429K | 3.49% | 8 |
|
|
2021
Q1 | $28.3M | Sell |
61,906
-2,672
| -4% | -$1.28M | 3.42% | 9 |
|
|
2020
Q4 | $30.1M | Sell |
64,578
-7,211
| -10% | -$3.38M | 3.87% | 6 |
|
|
2020
Q3 | $31.7M | Sell |
71,789
-3,850
| -5% | -$1.59M | 4.57% | 4 |
|
|
2020
Q2 | $27.4M | Sell |
75,639
-1,404
| -2% | -$471K | 4.67% | 3 |
|
|
2020
Q1 | $21.8M | Sell |
77,043
-6,711
| -8% | -$2.12M | 4.54% | 7 |
|
|
2019
Q4 | $27.2M | Buy |
83,754
+3,353
| +4% | +$1.02M | 3.84% | 7 |
|
|
2019
Q3 | $23.4M | Sell |
80,401
-4,769
| -6% | -$1.37M | 3.64% | 11 |
|
|
2019
Q2 | $25M | Sell |
85,170
-4,307
| -5% | -$1.19M | 3.92% | 9 |
|
|
2019
Q1 | $24.5M | Sell |
89,477
-4,680
| -5% | -$1.16M | 4.05% | 6 |
|
|
2018
Q4 | $21.1M | Sell |
94,157
-1,980
| -2% | -$465K | 3.76% | 9 |
|
|
2018
Q3 | $23.5M | Sell |
96,137
-2,000
| -2% | -$460K | 3.57% | 7 |
|
|
2018
Q2 | $20.3M | Sell |
98,137
-941
| -0.9% | -$200K | 3.45% | 9 |
|
|
2018
Q1 | $20.5M | Buy |
99,078
+1,144
| +1% | +$240K | 3.37% | 8 |
|
|
2017
Q4 | $18.6M | Sell |
97,934
-160
| -0.2% | -$30.7K | 3.16% | 12 |
|
|
2017
Q3 | $18.6M | Buy |
98,094
+2,825
| +3% | +$512K | 3.25% | 9 |
|
|
2017
Q2 | $16.6M | Buy |
95,269
+168
| +0.2% | +$28.2K | 3.16% | 12 |
|
|
2017
Q1 | $14.6M | Sell |
95,101
-7,773
| -8% | -$1.19M | 2.86% | 15 |
|
|
2016
Q4 | $14.5M | Buy |
102,874
+95
| +0.1% | +$14K | 3.1% | 13 |
|
|
2016
Q3 | $16.3M | Sell |
102,779
-3,870
| -4% | -$596K | 3.53% | 10 |
|
|
2016
Q2 | $15.8M | Sell |
106,649
-6,591
| -6% | -$973K | 3.43% | 10 |
|
|
2016
Q1 | $16M | Sell |
113,240
-890
| -0.8% | -$119K | 3.54% | 10 |
|
|
2015
Q4 | $16.2M | Buy |
114,130
+985
| +0.9% | +$131K | 3.66% | 10 |
|
|
2015
Q3 | $13.8M | Buy |
113,145
+2,783
| +3% | +$363K | 3.45% | 12 |
|
|
2015
Q2 | $14.3M | Sell |
110,362
-2,940
| -3% | -$383K | 3.3% | 11 |
|
|
2015
Q1 | $15.2M | Sell |
113,302
-1,400
| -1% | -$180K | 3.97% | 3 |
|
|
2014
Q4 | $14.4M | Buy |
114,702
+5,099
| +5% | +$620K | 3.8% | 6 |
|
|
2014
Q3 | $13.3M | Sell |
109,603
-5,012
| -4% | -$609K | 3.7% | 7 |
|
|
2014
Q2 | $13.5M | Buy |
114,615
+3,070
| +3% | +$361K | 3.64% | 10 |
|
|
2014
Q1 | $13.4M | Sell |
111,545
-16,558
| -13% | -$1.97M | 3.84% | 5 |
|
|
2013
Q4 | $14.3M | Sell |
128,103
-405
| -0.3% | -$40.3K | 4.18% | 1 |
|
|
2013
Q3 | $11.8M | Sell |
128,508
-2,930
| -2% | -$265K | 3.61% | 6 |
|
|
2013
Q2 | $11.1M | Buy |
+131,438
| New | +$10.9M | 3.65% | 7 |
|
Other funds holding TMO
VCM
Cornerstone Capital's TMO Position: Q1 2026 in Review
Cornerstone Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.82% in Q1 2026, selling an estimated $221K and leaving 49,377 shares worth $24.3M. The position accounts for 2.42% of the portfolio, ranked #13.
Cornerstone Capital first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.1M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Cornerstone Capital held 49,377 shares of Thermo Fisher Scientific worth $24.3M as of Q1 2026.
- Cornerstone Capital sold 408 Thermo Fisher Scientific shares in Q1 2026, an estimated $221K.
- Thermo Fisher Scientific made up 2.42% of Cornerstone Capital's portfolio in Q1 2026, its #13 holding.
- Cornerstone Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Cornerstone Capital's Thermo Fisher Scientific position peaked at $38.1M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Cornerstone Capital's 13F filing for Q1 2026, filed 12 May 2026.